Noninvasive Transcutaneous Vagal Nerve Stimulation (tcVNS) for Neuromodulating the Conscious State
NCT ID: NCT07191340
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-10-31
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
NCT04935697
Effect of taVNS on Patients With Disorders of Consciousness
NCT07284732
Transcutaneous Auricular Vagal Nerve Stimulation for Post-coma Patients With Disorders of Consciousness
NCT04065386
Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
NCT07219108
Vagal Nerve Stimulation to Treat Disorders of Consciousness
NCT06681168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group Stimulation of Vagus Nerve
Stimulation of the vagus nerve with nerve stimulator placed on neck
Vagus nerve stimulator
Vagus nerve stimulator placed on neck and activated
Sham Placebo Group No Stimulation to Vagus Nerve
Nerve stimulator placed on neck but not activated.
Placebo comparator sham
Vagus nerve stimulator placed on neck and not activated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vagus nerve stimulator
Vagus nerve stimulator placed on neck and activated
Placebo comparator sham
Vagus nerve stimulator placed on neck and not activated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing lumbar surgery for degenerative disc disease or spinal stenosis involving two or more levels
* Mini-Mental State Examination (MMSE) score ≥ 15-accept mild
* Ability to use a keyboard
* Able to understand and communicate in English
* Be able to consent independently
* Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study.
* Must not be involved in any other research intervention study testing neurobehavioral functioning
* Good internet connectivity and ability to use computer, smart phone or good telephone connectivity (follow up)
Exclusion Criteria
* History of vagotomy (cutting the vagus nerve)
* History of bradycardia, heart block, prolonged QT syndrome, brugada syndrome, heart failure with ejection fraction less than 35% and/or New York Heart Association symptoms
* MMSE \< 15
* History of seizure disorder or intracranial hemorrhage
* Patients with carotid stenosis
* Patients with aneurysms
* Other neurological diagnoses or a diagnosis of severe psychiatric disorder (e.g., psychosis) or a reported childhood learning disability
* Pregnancy, breastfeeding
* Active addiction history
* ECG adhesive allergy
* Severe aphasia, preventing subject from understanding the protocol and giving written consent
* Patients with an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
* Patients with metallic device such as a stent, bone plate or bone screw implanted at or near their neck
* Patients with an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
* Patients with metallic device such as a stent, bone plate or bone screw implanted at or near their neck
* Patients who are using another device at the same time (e.g., transcutaneous electrical nerve stimulation (TENS) Unit, muscle stimulator) or any portable electronic device (e.g., mobile phone).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alyson Engle, MD
Role: PRINCIPAL_INVESTIGATOR
Northwestern Univesity
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00217188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.